Actelion (Switzerland)

Institution (Company)

Homepage Wikipedia ROR

Also Known As

Actelion (Switzerland)

1.4K

Publications

176.3K

Citations

241

Authors

453

Concepts

About

Actelion (Switzerland) is a company institution in Allschwil, Switzerland known for medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	23	69	11.3K
2	Health Sciences	15	53	1.7K
3	Business	1	1	57
4	Education	1	1	11
5	Humanities	1	1	11

Actelion (Switzerland)

1.4K

Publications

176.3K

Citations

Page 1

	Year	Citations
Bosentan Therapy for Pulmonary Arterial Hypertension Lewis J. Rubin, David B. Badesch, Robyn J. Barst, New England Journal of Medicine	2002	2.7K
DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis Thomas Sander, Joël Freyss, Modest von Korff, Journal of Chemical Information and Modeling EngineeringHit IdentificationInteractive Data ExplorationData VisualizationData Exploration	2015	1.7K
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study Richard N. Channick, G Simonneau, Olivier Sitbon, The Lancet HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseasePlacebocontrolled Study	2001	1.5K
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension Tomás Pulido, Igor Adzerikho, Richard N. Channick, New England Journal of Medicine	2013	1.4K
Selexipag for the Treatment of Pulmonary Arterial Hypertension Olivier Sitbon, Richard N. Channick, Kelly Chin, New England Journal of Medicine	2015	1K
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial Nazzareno Galiè, LJ Rubin, Pavel Jansa, The Lancet HypertensionPulmonary Arterial HypertensionCardiovascular DiseaseAntihypertensive TherapyEarly Study	2008	913
Bosentan Therapy in Patients With Eisenmenger Syndrome Nazzareno Galiè, Maurice Beghetti, Michael Α. Gatzoulis, Circulation	2006	827
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study Gerry Coghlan, Christopher P. Denton, Ekkehard Grünig, Annals of the Rheumatic Diseases	2013	798
Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist J H Korn, Maureen D. Mayes, M Matucci Cerinic, Arthritis & Rheumatism	2004	720
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis Talmadge E. King, Kevin M. Brown, Ganesh Raghu, American Journal of Respiratory and Critical Care Medicine	2011	708

Page 1